Cargando…
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
BACKGROUND: Host immunity is emerging as a key player in the prognosis and response to treatment of cancer patients. However, the impact of the immune system and its modulation by therapies are unknown in rare soft tissue sarcomas such as solitary fibrous tumours (SFTs), whose management in the adva...
Autores principales: | Tazzari, M, Negri, T, Rini, F, Vergani, B, Huber, V, Villa, A, Dagrada, P, Colombo, C, Fiore, M, Gronchi, A, Stacchiotti, S, Casali, P G, Pilotti, S, Rivoltini, L, Castelli, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183857/ https://www.ncbi.nlm.nih.gov/pubmed/25101565 http://dx.doi.org/10.1038/bjc.2014.437 |
Ejemplares similares
-
Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013) -
Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours
por: Spagnuolo, Rosalin D., et al.
Publicado: (2016) -
Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types
por: Tazzari, Marcella, et al.
Publicado: (2018) -
Solitary fibrous tumour presenting with a single bone metastasis: report of six cases and literature review
por: Colia, Vittoria, et al.
Publicado: (2016) -
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
por: Tazzari, Marcella, et al.
Publicado: (2015)